title: A placebo-controlled trial of buspirone for the treatment of marijuana dependence.
abstract: The present study investigated the potential efficacy of buspirone for treating marijuana dependence. Participants received either buspirone (maximum 60mg/day) (n=23) or matching placebo (n=27) for 12 weeks, each in conjunction with motivational interviewing. In the modified intention-to-treat analysis, the percentage of negative UDS results in the buspirone-treatment group was 18 percentage points higher than the placebo-treatment group (95% CI: -2% to 37%, p=0.071). On self-report, participants receiving buspirone reported not using marijuana 45.2% of days and participants receiving placebo reported not using 51.4% of days (p=0.55). An analysis of participants that completed the 12-week trial showed a significant difference in the percentage negative UDS (95% CI: 7-63%, p=0.014) and a trend for participants randomized to the buspirone-treatment group who completed treatment to achieve the first negative UDS result sooner than those participants treated with placebo (p=0.054). Further study with buspirone in this population may be warranted; however, strategies to enhance study retention and improve outcome measurement should be considered in future trials.
authors.affiliation: Department of Psychiatry, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA. mcraeal@musc.edu
authors.forename: Aimee L
authors.initials: AL
authors.lastname: McRae-Clark
authors.forename: Rickey E
authors.initials: RE
authors.lastname: Carter
authors.forename: Therese K
authors.initials: TK
authors.lastname: Killeen
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Carpenter
authors.forename: Amy E
authors.initials: AE
authors.lastname: Wahlquist
authors.forename: Stacey A
authors.initials: SA
authors.lastname: Simpson
authors.forename: Kathleen T
authors.initials: KT
authors.lastname: Brady
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D002065:Buspirone / Q000009:adverse effects / Q000627:therapeutic use*; D002186:Cannabinoids / Q000652:urine; D002188:Cannabis / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000188:drug therapy* / Q000523:psychology / Q000652:urine; D009042:Motivation; D011569:Psychiatric Status Rating Scales; D018401:Sample Size; D013375:Substance Withdrawal Syndrome / Q000453:epidemiology / Q000523:psychology; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D014151:Anti-Anxiety Agents; D002186:Cannabinoids; D002065:Buspirone
references.citation: Am J Addict. 2007 Sep-Oct;16(5):331-42
references.pmid: 17882603
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2000 Jan;361(1):19-24
references.pmid: 10651142
references.citation: Neurochem Res. 2005 Aug;30(8):1037-43
references.pmid: 16258853
references.citation: Drug Alcohol Depend. 1999 Apr 1;54(2):127-35
references.pmid: 10217552
references.citation: Am J Psychiatry. 2004 Nov;161(11):1967-77
references.pmid: 15514394
references.citation: Addict Behav. 1979;4(4):361-71
references.pmid: 525504
references.citation: Arch Gen Psychiatry. 2001 Aug;58(8):755-61
references.pmid: 11483141
references.citation: Addiction. 2001 Jul;96(7):1023-34
references.pmid: 11440613
references.citation: J Stud Alcohol Suppl. 1994 Dec;12:70-5
references.pmid: 7723001
references.citation: J Clin Pharmacol. 1994 Mar;34(3):222-4
references.pmid: 8021329
references.citation: Ther Drug Monit. 2005 Dec;27(6):799-810
references.pmid: 16306858
references.citation: Pharmacol Biochem Behav. 2003 Jul;75(4):777-87
references.pmid: 12957219
references.citation: Am J Addict. 2006 Sep-Oct;15(5):404
references.pmid: 16966201
references.citation: Psychopharmacologia. 1973 Oct 23;33(1):53-70
references.pmid: 4358666
references.citation: Curr Opin Psychiatry. 2006 May;19(3):233-8
references.pmid: 16612207
references.citation: Am J Addict. 2006 Jan-Feb;15(1):8-14
references.pmid: 16449088
references.citation: J Anal Toxicol. 1998 Oct;22(6):445-54
references.pmid: 9788519
references.citation: J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):67S-76S
references.pmid: 2198303
references.citation: Addiction. 1999 Sep;94(9):1311-22
references.pmid: 10615717
references.citation: Biochem Pharmacol. 2001 Jun 1;61(11):1357-67
references.pmid: 11331071
references.citation: Exp Clin Psychopharmacol. 2000 Nov;8(4):483-92
references.pmid: 11127420
references.citation: Exp Clin Psychopharmacol. 2002 Feb;10(1):54-63
references.pmid: 11866252
references.citation: Br J Psychiatry Suppl. 1991 Sep;(12):45-51
references.pmid: 1840763
references.citation: Pharmacotherapy. 1997 May-Jun;17(3):497-510
references.pmid: 9165553
references.citation: J Consult Clin Psychol. 1993 Jun;61(3):455-61
references.pmid: 8326047
references.citation: Drug Alcohol Depend. 2004 Aug 16;75(2):123-34
references.pmid: 15276217
references.citation: JAMA. 1990 Nov 21;264(19):2511-8
references.pmid: 2232018
references.citation: J Clin Psychiatry. 2006 Feb;67(2):247-57
references.pmid: 16566620
references.citation: Psychopharmacology (Berl). 1982;76(3):245-50
references.pmid: 6285406
references.citation: Am J Addict. 2004 Jan-Feb;13(1):21-32
references.pmid: 14766435
references.citation: Clin Pharm. 1984 Nov-Dec;3(6):600-7
references.pmid: 6150781
references.citation: J Subst Abuse Treat. 2003 Jun;24(4):369-76
references.pmid: 12867212
references.citation: Arch Gen Psychiatry. 1994 Jul;51(7):568-76
references.pmid: 8031230
references.citation: Clin Pharmacol Ther. 1976 Mar;19(3):300-9
references.pmid: 770048
references.citation: Drug Alcohol Depend. 2008 Apr 1;94(1-3):254-7
references.pmid: 18182254
references.citation: Br J Med Psychol. 1959;32(1):50-5
references.pmid: 13638508
references.citation: Drug Metab Dispos. 1995 Aug;23(8):825-31
references.pmid: 7493549
references.citation: Int J Neuropsychopharmacol. 2006 Jun;9(3):277-86
references.pmid: 15967059
references.citation: Eur J Pharmacol. 1983 Mar 18;88(1):137-8
references.pmid: 6133764
references.citation: Eur J Pharmacol. 1974 Sep;28(1):172-7
references.pmid: 4609777
references.citation: Am J Drug Alcohol Abuse. 2002 Nov;28(4):643-52
references.pmid: 12492261
references.citation: Subst Use Misuse. 1997 Feb;32(3):249-64
references.pmid: 9058474